A follow-up study for left ventricular mass on chromosome 12p11 identifies potential candidate genes

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Della Morte, David ^a,c   Beecham, Ashley ^a   Rundek, Tatjana ^a   Wang, Liyong ^a   McClendon, Mark S ^a   Slifer, Susan ^a   Blanton, Susan H ^a   Di Tullio, Marco R ^b   Sacco, Ralph L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR SOX5; SOX5 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

AGED; ARTICLE; CARDIOVASCULAR RISK; CHROMOSOME 12P; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENE; GENE CONTROL; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC MODEL; GENOTYPE; HEART LEFT VENTRICLE MASS; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; ABDOMINAL OBESITY; BIOLOGICAL MODEL; CHROMOSOME 12; DOMINICAN REPUBLIC; GENETICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART VENTRICLE; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; STATISTICS; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 12; DOMINICAN REPUBLIC; FEMALE; FOLLOW-UP STUDIES; GENETIC ASSOCIATION STUDIES; HEART VENTRICLES; HISPANIC AMERICANS; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; LOD SCORE; MALE; MIDDLE AGED; MODELS, GENETIC; OBESITY, ABDOMINAL; ORGAN SIZE; POLYMORPHISM, SINGLE NUCLEOTIDE; SOXD TRANSCRIPTION FACTORS; WAIST CIRCUMFERENCE;

EID: 79960681029     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-100     Document Type: Article

References (48)

1. Lorell BH, Carabello BA. Left ventricular hypertrophy: pathogenesis, detection, and prognosis. Circulation 2000, 102(4):470-479.
2. Gosse P, Dallocchio M. Left ventricular hypertrophy: epidemiological prognosis and associated critical factors. Eur Heart J 1993, 14(Suppl D):16-21.
3. Rodriguez CJ, Lin F, Sacco RL, Jin Z, Boden-Albala B, Homma S, Di Tullio MR. Prognostic implications of left ventricular mass among Hispanics: the Northern Manhattan Study. Hypertension 2006, 48(1):87-92. 10.1161/01.HYP.0000223330.03088.58, 16651457.
4. Artham SM, Lavie CJ, Milani RV, Patel DA, Verma A, Ventura HO. Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis 2009, 52(2):153-167. 10.1016/j.pcad.2009.05.002, 19732607.
5. Celentano A, Palmieri V, Esposito ND, Pietropaolo I, Crivaro M, Mureddu GF, Devereux RB, de Simone G. Inappropriate left ventricular mass in normotensive and hypertensive patients. Am J Cardiol 2001, 87(3):361-363, A310. 10.1016/S0002-9149(00)01379-5, 11165981.
6. Sharma P, Middelberg RP, Andrew T, Johnson MR, Christley H, Brown MJ. Heritability of left ventricular mass in a large cohort of twins. J Hypertens 2006, 24(2):321-324. 10.1097/01.hjh.0000202815.18083.03, 16508579.
7. Arnett DK, de las Fuentes L, Broeckel U. Genes for left ventricular hypertrophy. Curr Hypertens Rep 2004, 6(1):36-41. 10.1007/s11906-004-0009-5, 14972088.
8. Juo SH, Di Tullio MR, Lin HF, Rundek T, Boden-Albala B, Homma S, Sacco RL. Heritability of left ventricular mass and other morphologic variables in Caribbean Hispanic subjects: the Northern Manhattan Family Study. J Am Coll Cardiol 2005, 46(4):735-737. 10.1016/j.jacc.2005.05.025, 2692931, 16098447.
9. Wang L, Beecham A, Di Tullio MR, Slifer S, Blanton SH, Rundek T, Sacco RL. Novel quantitative trait locus is mapped to chromosome 12p11 for left ventricular mass in Dominican families: the Family Study of Stroke Risk and Carotid Atherosclerosis. BMC Med Genet 2009, 10:74. 2724377, 19627612.
10. Sacco RL, Sabala EA, Rundek T, Juo SH, Huang JS, DiTullio M, Homma S, Almonte K, Lithgow CG, Boden-Albala B. Design of a family study among high-risk Caribbean Hispanics: the Northern Manhattan Family Study. Ethn Dis 2007, 17(2):351-357. 2556080, 17682370.
11. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, Paik MC. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke 2004, 35(10):2263-2269. 10.1161/01.STR.0000142374.33919.92, 15345803.
12. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978, 58(6):1072-1083.
13. Di Tullio MR, Zwas DR, Sacco RL, Sciacca RR, Homma S. Left ventricular mass and geometry and the risk of ischemic stroke. Stroke 2003, 34(10):2380-2384. 10.1161/01.STR.0000089680.77236.60, 2812917, 12958319.
14. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57(6):450-458. 10.1016/0002-9149(86)90771-X, 2936235.
15. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 2006, 38(8):904-909. 10.1038/ng1847, 16862161.
16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 2007, 81(3):559-575. 10.1086/519795, 1950838, 17701901.
17. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143-3421.
18. Gao X, Starmer J, Martin ER. A multiple testing correction method for genetic association studies using correlated single nucleotide polymorphisms. Genet Epidemiol 2008, 32(4):361-369. 10.1002/gepi.20310, 18271029.
19. Gauderman WJ. Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 2002, 21(1):35-50. 10.1002/sim.973, 11782049.
20. Fox ER, Klos KL, Penman AD, Blair GJ, Blossom BD, Arnett D, Devereux RB, Samdarshi T, Boerwinkle E, Mosley TH. Heritability and Genetic Linkage of Left Ventricular Mass, Systolic and Diastolic Function in Hypertensive African Americans (From the GENOA Study). Am J Hypertens 2010, 23(8):870-5. 10.1038/ajh.2010.67, 20448532.
21. Hu BC, Li L, Sun RH, Gao PJ, Zhu DL, Wang JG, Chu SL. The association between transforming growth factor beta3 polymorphisms and left ventricular structure in hypertensive subjects. Clin Chim Acta 2010, 411:(7-8):558-562. 10.1016/j.cca.2009.09.029, 19799891.
22. Horio T, Kamide K, Takiuchi S, Yoshii M, Miwa Y, Matayoshi T, Yoshihara F, Nakamura S, Tokudome T, Miyata T, Kawano Y. Association of insulin-like growth factor-1 receptor gene polymorphisms with left ventricular mass and geometry in essential hypertension. J Hum Hypertens 2010, 24(5):320-326. 10.1038/jhh.2009.73, 19759555.
23. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet 1998, 18(1):45-48. 10.1038/ng0198-45, 9425898.
24. Kupari M, Hautanen A, Lankinen L, Koskinen P, Virolainen J, Nikkila H, White PC. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. Circulation 1998, 97(6):569-575.
25. Braam B, de Roos R, Bluyssen H, Kemmeren P, Holstege F, Joles JA, Koomans H. Nitric oxide-dependent and nitric oxide-independent transcriptional responses to high shear stress in endothelial cells. Hypertension 2005, 45(4):672-680. 10.1161/01.HYP.0000154683.33414.94, 15699468.
26. Hua L, Li C, Xia D, Qu P, Li Z, Zhang W, Feng X. Relationship between hypertensive left ventricular hypertrophy and levels of endothelin and nitric oxide. Hypertens Res 2000, 23(4):377-380. 10.1291/hypres.23.377, 10912776.
27. Zheng Z, Wang ZM, Delbono O. Charge movement and transcription regulation of L-type calcium channel alpha(1S) in skeletal muscle cells. J Physiol 2002, 540(Pt 2):397-409. 2290248, 11956331.
28. Benitah JP, Alvarez JL, Gomez AM. L-type Ca(2+) current in ventricular cardiomyocytes. J Mol Cell Cardiol 2010, 48(1):26-36. 10.1016/j.yjmcc.2009.07.026, 19660468.
29. Pfeufer A, van Noord C, Marciante KD, Arking DE, Larson MG, Smith AV, Tarasov KV, Müller M, Sotoodehnia N, Sinner MF, Verwoert GC, Li M, Kao WH, Köttgen A, Coresh J, Bis JC, Psaty BM, Rice K, Rotter JI, Rivadeneira F, Hofman A, Kors JA, Stricker BH, Uitterlinden AG, van Duijn CM, Beckmann BM, Sauter W, Gieger C, Lubitz SA, Newton-Cheh C, et al. Genome-wide association study of PR interval. Nat Genet 2010, 42(2):153-159. 10.1038/ng.517, 2850197, 20062060.
30. Wakefield L, Cornish V, Broackes-Carter F, Sim E. Arylamine N-acetyltransferase 2 expression in the developing heart. J Histochem Cytochem 2005, 53(5):583-592. 10.1369/jhc.4A6496.2005, 15872051.
31. Mangino M, Brouilette S, Braund P, Tirmizi N, Vasa-Nicotera M, Thompson JR, Samani NJ. A regulatory SNP of the BICD1 gene contributes to telomere length variation in humans. Hum Mol Genet 2008, 17(16):2518-2523. 10.1093/hmg/ddn152, 18487243.
32. Saliques S, Zeller M, Lorin J, Lorgis L, Teyssier JR, Cottin Y, Rochette L, Vergely C. Telomere length and cardiovascular disease. Arch Cardiovasc Dis 2010, 103:(8-9):454-459.
33. Swift S, Xu J, Trivedi V, Austin KM, Tressel SL, Zhang L, Covic L, Kuliopulos A. A novel protease-activated receptor-1 interactor, Bicaudal D1, regulates G protein signaling and internalization. J Biol Chem 2010, 285(15):11402-11410. 10.1074/jbc.M110.105403, 2857018, 20164183.
34. Mishra PK, Metreveli N, Tyagi SC. MMP-9 gene ablation and TIMP-4 mitigate PAR-1-mediated cardiomyocyte dysfunction: a plausible role of dicer and miRNA. Cell Biochem Biophys 2010, 57(2-3):67-76. 10.1007/s12013-010-9084-1, 2921878, 20422465.
35. Seguin L, Liot C, Mzali R, Harada R, Siret A, Nepveu A, Bertoglio J. CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP, and MKLP1 in S phase. Mol Cell Biol 2009, 29(2):570-581. 10.1128/MCB.01275-08, 2612504, 19015243.
36. Hayashi H, Takahata S. Role of peroxisomal fatty acyl-CoA beta-oxidation in phospholipid biosynthesis. Arch Biochem Biophys 1991, 284(2):326-331. 10.1016/0003-9861(91)90303-Z, 1989516.
37. Ribot E, Grandgirard A, Sebedio JL, Grynberg A, Athias P. Incorporation of cyclic fatty acid monomers in lipids of rat heart cell cultures. Lipids 1992, 27(1):79-81. 10.1007/BF02537066, 1608311.
38. Rodrigues SL, Angelo LC, Pereira AC, Krieger JE, Mill JG. Determinants of left ventricular mass and presence of metabolic risk factors in normotensive individuals. Int J Cardiol 2009, 135(3):323-330. 10.1016/j.ijcard.2008.03.066, 18929416.
39. Tsioufis CP, Tsiachris DL, Selima MN, Dimitriadis KS, Thomopoulos CG, Tsiliggiris DC, Gennadi AS, Syrseloudis DC, Stefanadi ES, Toutouzas KP, Kallikazaros IE, Stefanadis CI. Impact of waist circumference on cardiac phenotype in hypertensives according to gender. Obesity (Silver Spring) 2009, 17(1):177-182.
40. Verhaaren HA, Schieken RM, Mosteller M, Hewitt JK, Eaves LJ, Nance WE. Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia twin study). Am J Cardiol 1991, 68(6):661-668. 10.1016/0002-9149(91)90361-N, 1877484.
41. Smith NL, Felix JF, Morrison AC, Demissie S, Glazer NL, Loehr LR, Cupples LA, Dehghan A, Lumley T, Rosamond WD, Lieb W, Rivadeneira F, Bis JC, Folsom AR, Benjamin E, Aulchenko YS, Haritunians T, Couper D, Murabito J, Wang YA, Stricker BH, Gottdiener JS, Chang PP, Wang TJ, Rice KM, Hofman A, Heckbert SR, Fox ER, O'Donnell CJ, Uitterlinden AG, et al. Association of genome-wide variation with the risk of incident heart failure in adults of European and African ancestry: a prospective meta-analysis from the cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium. Circ Cardiovasc Genet 2010, 3(3):256-266. 10.1161/CIRCGENETICS.109.895763, 3025695, 20445134.
42. Talmud PJ, Drenos F, Shah S, Shah T, Palmen J, Verzilli C, Gaunt TR, Pallas J, Lovering R, Li K, Casas JP, Sofat R, Kumari M, Rodriguez S, Johnson T, Newhouse SJ, Dominiczak A, Samani NJ, Caulfield M, Sever P, Stanton A, Shields DC, Padmanabhan S, Melander O, Hastie C, Delles C, Ebrahim S, Marmot MG, Smith GD, Lawlor DA, et al. Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet 2009, 85(5):628-642. 10.1016/j.ajhg.2009.10.014, 2775832, 19913121.
43. Zhao FQ, Keating AF. Functional properties and genomics of glucose transporters. Curr Genomics 2007, 8(2):113-128. 10.2174/138920207780368187, 2435356, 18660845.
44. Wilker E, Mittleman MA, Litonjua AA, Poon A, Baccarelli A, Suh H, Wright RO, Sparrow D, Vokonas P, Schwartz J. Postural changes in blood pressure associated with interactions between candidate genes for chronic respiratory diseases and exposure to particulate matter. Environ Health Perspect 2009, 117(6):935-940. 2702409, 19590686.
45. Harzheim D, Movassagh M, Foo RS, Ritter O, Tashfeen A, Conway SJ, Bootman MD, Roderick HL. Increased InsP3Rs in the junctional sarcoplasmic reticulum augment Ca2+ transients and arrhythmias associated with cardiac hypertrophy. Proc Natl Acad Sci USA 2009, 106(27):11406-11411. 10.1073/pnas.0905485106, 2708695, 19549843.
46. Kockskamper J, Zima AV, Roderick HL, Pieske B, Blatter LA, Bootman MD. Emerging roles of inositol 1,4,5-trisphosphate signaling in cardiac myocytes. J Mol Cell Cardiol 2008, 45(2):128-147. 10.1016/j.yjmcc.2008.05.014, 2654363, 18603259.
47. Futatsugi A, Nakamura T, Yamada MK, Ebisui E, Nakamura K, Uchida K, Kitaguchi T, Takahashi-Iwanaga H, Noda T, Aruga J, Mikoshiba K. IP3 receptor types 2 and 3 mediate exocrine secretion underlying energy metabolism. Science 2005, 309(5744):2232-2234. 10.1126/science.1114110, 16195467.
48. Salpea KD, Talmud PJ, Cooper JA, Maubaret CG, Stephens JW, Abelak K, Humphries SE. Association of telomere length with type 2 diabetes, oxidative stress and UCP2 gene variation. Atherosclerosis 2010, 209(1):42-50. 10.1016/j.atherosclerosis.2009.09.070, 2839074, 19889414.